Utility of Epstein-Barr Virus Biomarkers in Human Immunodeficiency Virus–related Lymphomas in the Modern Combined Antiretroviral Therapy Era - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Clinical Infectious Diseases Année : 2019

Utility of Epstein-Barr Virus Biomarkers in Human Immunodeficiency Virus–related Lymphomas in the Modern Combined Antiretroviral Therapy Era

Fichier non déposé

Dates et versions

hal-02059871 , version 1 (07-03-2019)

Identifiants

Citer

Julien Lupo, Raphaële Germi, Dominique Costagliola, Patrice Morand, Caroline Besson. Utility of Epstein-Barr Virus Biomarkers in Human Immunodeficiency Virus–related Lymphomas in the Modern Combined Antiretroviral Therapy Era. Clinical Infectious Diseases, 2019, 68 (5), pp.891-892. ⟨10.1093/cid/ciy786⟩. ⟨hal-02059871⟩
47 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More